Navigation Links
Paris Dates for CPhI Worldwide 2010
Date:6/15/2009

MAARSSEN, Netherlands, June 15 /PRNewswire/ -- CPhI Worldwide returns to Paris for 2010 when, with ICSE, PMEC and BioPh, the world's leading pharma services industry event will be staged at Paris-Nord Villepinte on Tuesday 5 - Thursday 7 October. This is a week earlier than the 2009 event in Madrid, but close to the dates of the last staging in Paris, in 2006.

Organisers UBM International Media expect the quartet of co-located events to rival the 25,000+ attendees expected this year in Madrid. The 2006 events in Paris hosted over 22,000 attendees.

Full details of the 2010 events - the twenty first CPhI Worldwide - will be announced later this year. These will certainly include the multi-track Where Pharma Meets modular seminar sessions on the pre-shows afternoon of Monday 4 October, which debut this year in Madrid.

Breakfast Briefings will be back for a third year, and 2010 will also see the return of the CPhI Innovation Awards and Speakers' Corner features within both CPhI and ICSE.

Eliane van Doorn, UBM International Media's Group Director for Pharma Ingredients Events, commented: "The industry has seen some significant business challenges since our last visit to Paris. Back in 2006 we had just launched P-MEC on the prior year's visit to Madrid. This year, we also launch BioPh in Madrid and will similarly move to Paris for 2010 with the momentum of newly-launched features."

And she continued: "One of the dominant changes since 2006 has been the strong convergence of the bio and pharma business models, especially in ingredients and contract services. We expect this to be a strong continuing theme, with CPhI Worldwide strengthening further as the senior networking platform for pharma production interests".

CPhI Worldwid
'/>"/>

SOURCE CPhI Worldwide
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Celadrin(R) Research Unveiled at Nutrigenomics 2008 Meeting in Paris, France
2. Physician to Implant the CATANIA(TM) Coronary Stent System With Polyzene(R)-F to Treat Chronic Total Occlusion During Live Case at the Paris Cardiovascular Interventions Course (Francophone) 2008
3. Huntsman Innovation Wins Top Award at Paris JEC Show
4. Baxa Announces 2008 Dates for STAR Center Professional Pharmacy and Cleanroom Training
5. SemBioSys updates Apo AI development program
6. Strategic Diagnostics Updates Roth Conference Presentation Time
7. KineMed to Collaborate With Merck KgaA to Validate New Applications for Drug Development Candidates
8. Pieris Validates the Use of Anticalins(R) as Ophthalmologic Biotherapeutics
9. Arius Features Preclinical Data on Antibody Candidates at Two Conferences
10. PAREXEL International Updates Financial Guidance in Conjunction with the Acquisition of APEX International Clinical Research Co., Ltd. and Other Factors
11. BioSpace Draws Over 600 Candidates to San Diego Life Science Career Fair
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... FL (PRWEB) May 22, 2013 A recent ... of probiotics on athletes to find that those who took ... longer. The results from the study showed that in extreme ... Action, known for their adult acne treatment explains ... and how it may help their skin condition. , ...
(Date:5/22/2013)... Mass. , May 22, 2013  Moderna Therapeutics, ... new treatment modality to enable the in vivo ... John Reynders will join Moderna in ... Reynders is a proven leader in the ... of drug development, from discovery to translation, clinical operations ...
(Date:5/21/2013)... BEACH, Fla. , May 21, 2013 /PRNewswire/ ... FCN ), the global business advisory ... their enterprise value (the "Company"), announced that it ... personnel that were formerly included within the Corporate ... Litigation Consulting segment to form a single integrated ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Custom ... to reporting eLearning solution using Tin Can API ... dashboard tool. CLD is a leading developer of ... medical device companies worldwide. , Tin Can ... that helps learners and trainers more accurately measure ...
Breaking Biology Technology:Adult Acne Treatment, Probiotic Action Shares Insight on New Findings Between Probiotics and Heat Tolerance, and What It Means for Acne Sufferers 2Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 2Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 3FTI Consulting Releases Realigned Segment Information Reflecting Newly Combined Health Solutions Practice 2CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 2CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 3
... Singapore investigators to coordinate 700 patient trial of ... of head and neck cancer,MISSISSAUGA, ON, Jan. 5 ... TSX:YM, AIM:YMBA), an oncology company that identifies, develops ... announced that the National Cancer Centre of Singapore ...
... Penn Allegheny,Health System and The Western Pennsylvania Hospital announced ... Jones, MD, FACS,and Roger R. Barrette, MD, formerly of ... Drs. Jones and Barrette will direct the ... for the treatment of burn injuries. West Penn,is ...
... the backdrop of a flagging,economy, bailouts, and bleak ... with a future as bright as New Year,s ... market the Embozene(TM),Color-Advanced Microspheres embolization platform for the ... of blood vessels in many,locations) and arteriovenous malformations ...
Cached Biology Technology:YM BIOSCIENCES' NIMOTUZUMAB SELECTED FOR MULTINATIONAL PHASE III TRIAL BY NATIONAL CANCER CENTRE OF SINGAPORE 2YM BIOSCIENCES' NIMOTUZUMAB SELECTED FOR MULTINATIONAL PHASE III TRIAL BY NATIONAL CANCER CENTRE OF SINGAPORE 3YM BIOSCIENCES' NIMOTUZUMAB SELECTED FOR MULTINATIONAL PHASE III TRIAL BY NATIONAL CANCER CENTRE OF SINGAPORE 4West Penn Allegheny Health System Announces Recruitment of Leading Burn Specialists 2West Penn Allegheny Health System Announces Recruitment of Leading Burn Specialists 3First U.S. Implants of Newly Approved Embozene(TM) Color-Advanced Microspheres Embolization Platform 2First U.S. Implants of Newly Approved Embozene(TM) Color-Advanced Microspheres Embolization Platform 3First U.S. Implants of Newly Approved Embozene(TM) Color-Advanced Microspheres Embolization Platform 4
(Date:5/21/2013)... , Where? Copenhagen, Denmark: Bella Center Congress ... , Why? An annual meeting ... developments, manufacturing and installation, drawing on leading experiences from ... edition from a record of more than 900 abstracts ... plenary and oral presentations, more than 460 visual presentation, ...
(Date:5/21/2013)... May 21, 2013 Royal Philips Electronics (NYSE: ... world,s first portable ultrasound with Philips, industry leading Live ... The CX50 xMATRIX with available Live 3D TEE and ... at the EuroPCR, official meeting for the European ... Since its launch in 2012, Philips CX50 xMATRIX ...
(Date:5/20/2013)... the antibiotic colistin are also commonly resistant to ... to a study in mBio , the ... Microbiology. Cross-resistance to colistin and host antimicrobials LL-37 ... bacterial attack, could mean that patients with life-threatening ... crippled immune response. Colistin is a last-line drug ...
Breaking Biology News(10 mins):21st European Biomass Conference and Exhibition 221st European Biomass Conference and Exhibition 321st European Biomass Conference and Exhibition 4Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3
... FASEB Journal provide more evidence that if we ... improve. According to MIT scientists, dietary nutrients found in ... eggs increase brain synapses and improve cognitive abilities. ... animals, respond to this kind of treatment by making ...
... State University faculty member who uses computational techniques ... is attracting worldwide attention from other researchers. ... and biomedical engineering at the Florida A&M University-Florida ... computers to determine how substances known as recombinant ...
... alarmed by the dramatic decline of at least 30 percent ... Nepal, once a refuge that boasted among the highest densities ... survey of April 2008 showed a population of between 6-14 ... Government of Nepal made a low-key announcement on July 1 ...
Cached Biology News:FSU researcher using computers to hone cancer-fighting strategies 2Tigers disappear from Himalayan refuge 2
...
... antibody recognizes 30% of IgM-rheumatoid ... It does not cross-react with IgM, ... factor nor with pooled F(Ab)2 fragments. ... ELISA to detect rheumatoid factor. Product ...
...
Salmonella typhimurium Immunogen: Heat inactivated bacterial cells of Salmonella typhimurium B Storage: 4 C...
Biology Products: